FDA Regulations for Marketing OTC Drugs in the U.S. 2015 is a webinar that covers topics such as:
- Different Ways that OTC Drugs can be Marketed in the U.S. (NDA, Rx to OTC Switch vs. Monograph process)
- Background and History of OTC Drug regulations
- FDA Drug Facts Labelling Requirements
- Overview of the OTC Drug Monographs and Their Importance
- FDA Regulations for Required Adverse Event Reporting
FDA Regulations for Marketing OTC Drugs in the U.S. 2015 is intended for:
- QA Managers
- Regulatory Affairs Managers and Associates
- Anyone interested in learning about U. S. OTC Drug regulatory requirements and compliance
- OTC Drug Marketing Managers
